$1 Million Lefkofsky Gift to Address Life-Threatening Diseases

Author | Kristy Demas

Eric Lefkofsky, AB '91, JD '93, has long operated on the cutting edge professionally. The founder of Groupon, LightBank, and most recently, Tempus — a biotechnology company — approaches philanthropy much the same way: encouraging innovation by investing in transformative ideas. 

Through the Lefkofsky Family Foundation, Eric and Liz Lefkofsky have announced a $1 million gift to Michigan Medicine to encourage early-career scientists to pursue high-risk, high-impact projects. This gift leverages and serves as a continuation of their support for groundbreaking research made possible through their gift in 2015. The new pledge not only leverages that support, but expands its scope to include COVID-19 — driving innovation in this area of urgent need. 

"We are delighted to be part of these meaningful projects that show such promise in changing the course of diseases considered difficult if not impossible to treat. It is gratifying to help get exciting research like this off the ground, offering better diagnoses, treatments, and potential cures to the many people impacted by these devastating conditions — including members of our own families."  —Eric Lefkofsky

Family histories of cancer and heart disease inspired Eric and his wife, Liz, in establishing the Eric and Liz Lefkofsky Innovation Research Fund at Michigan Medicine five years ago. Their goal: to support bold research addressing — and possibly solving— some of medicine's most challenging and unassailable diseases. 

With its #1 ranking in research volume among U.S. public research institutions, its focus on the biosciences and precision health, and its numerous opportunities for multidisciplinary collaboration, U-M provided fertile ground for the magnitude of scientific discovery the Lefkofskys wanted to fund. In addition, the awards were geared to take innovative research ideas forward by helping junior faculty generate the pilot data necessary to apply for federal and foundation financial support. 

In 2015, the Lefkofsky Awards went to teams — early-career scholars supported by strong mentors — focusing on triple-negative breast cancer, pancreatic cancer, and abnormal heart rhythm conditions. Since that time, tremendous progress has been made. 

In their triple-negative breast cancer project, Monika Burness, M.D., with mentors Daniel Hayes, M.D., and Sofia D. Merajver (M.D. 1987, Residency 1991, Fellowship 1993), Ph.D., assessed how these tumors respond to various drugs and why some tumors resist the effects of radiation — refining treatment options for individual patients. Sunitha Nagrath, Ph.D., and mentor Joerg Lahann, Ph.D., explored new methods of detecting pancreatic cancer for earlier and more accurate diagnoses — for better outcomes. Todd Herron, Ph.D., and Sharlene Day, M.D. (Residency 1998, Fellowship 2001), with mentors José Jalife, M.D., and David Pinsky, M.D., gained a better understanding of the relationship between the thickening of heart muscles and abnormal rhythms — identifying potential new effective technologies for personalized treatments. 

The successes experienced by the first round of Lefkofsky awardees resonate with Eric Lefkofsky. "We are delighted to be part of these meaningful projects that show such promise in changing the course of diseases considered difficult if not impossible to treat. It is gratifying to help get exciting research like this off the ground, offering better diagnoses, treatments, and potential cures to the many people impacted by these devastating conditions — including members of our own families." 

As with the awards made in 2015, proposals related to the new gift will be reviewed by a faculty committee with input from the Lefkofskys. In addition to breast cancer and cardiovascular disease, preference will also be given to projects addressing COVID-19 and neurodegenerative disorders. Kim Eagle, M.D., a director of the Samuel and Jean Frankel Cardiovascular Center, will once again oversee the process — a role he's more than happy to play. 

"Eric and Liz Lefkofsky have made another investment in the future of medicine, and I am honored to continue helping advance such promising scientific discovery. Gifts like theirs truly support and embody Michigan Medicine's mission of providing excellence in patient care while offering hope for the future." 


More Articles About: Philanthropy donation gift fundraising Lefkofsky high-risk high-impact Research
Featured News & Stories Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Access to Plan B coincides with a drastic decrease in emergency contraception-related ER visits, study shows
U.S. emergency departments see 96% fewer visits, $7.6 million less in medical costs after FDA approval of over the counter emergency contraception.
News Release
Statewide cardiovascular consortium, hosted at Michigan Medicine, receives national award for patient safety, quality efforts
A collaborative partnership dedicated to improving statewide cardiovascular care and outcomes — hosted at Michigan Medicine — received national recognition for efforts in patient safety and quality. BMC2 received the award for its significant improvements in the documentation of radiation use, a decrease in high-dose radiation exposure and reduction in opioid prescribing rates for patients.
Julie
Philanthropy News
A Family’s Cancer Journey and Loss Inspire an Oncology Nursing Excellence Award
Julie was a master gardener who grew up on a fruit farm in southwest Michigan. She also had a family history of cancer, which sadly foreshadowed her own ovarian cancer diagnosis.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Identifying Dementia from EHR Data
In 2009, the Health Information Technology for Economic and Clinical Health Act, wow, that's a mouthful, more commonly known as the HITECH Act, spent billions to promote the uptake of electronic health records by US hospitals. Fast forward more than a decade later, and now approximately four out of five healthcare institutions have electronic health record systems in place that integrate clinical notes, test results, medications, diagnostic images, et cetera. The adoption of EHR systems into healthcare introduces new and exciting opportunities to extract information that can be used to augment other types of data for research. As you might imagine though, it can be tricky to pull out meaningful information from the text of clinical notes. In this episode, we'll speak with a University of Michigan researcher, Dr. Vinod Vydiswaran, who's been developing methods to identify dementia from EHR data.
Little boy dressed as a super hero on an comic book background
Philanthropy News
Shining a Spotlight on Congenital Heart Defects
The Save A Heart campaign fundraising effort helps make advancements in research, treatments, and care for children with heart defects possible and raises awareness of people born with heart conditions.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Study finds bipolar disorder surpasses smoking in mortality risk
A large study shows having bipolar disorder is associated with a four- to six-fold risk of dying prematurely, suggesting more preventive efforts needed. Visit Health Lab to read the full story.